Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 3Breast 3Head & Neck 2Dermatologic 2Sarcoma 1Other solid neoplasm 1Genitourinary 1

Conditions

Solid Tumors 11Mesothelioma, Malignant 8Solid Tumor 6Advanced Solid Tumor 6Mesothelioma 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Treatment-Refractory Solid Tumors 2Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Merkel Cell 2Wilms Tumor 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Solid Tumour 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Select Advanced Solid Tumors 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Solid Tumors 1Locally Advanced Solid Tumor 1Kidney Neoplasms 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Gastrointestinal Neoplasms 1

Interventions

durvalumab 1cemiplimab 1avelumab 1atezolizumab 1Plicamycin 1Nivolumab 1Immune Checkpoint Inhibitors 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × atezolizumab × Other solid neoplasm × Clear all
NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡